Foreign firms looking to market general cosmetic products in China may still be faced with mandatory animal testing or extensive administrative red tape to avoid it, unless changes are made to draft regulations implementing the Cosmetics Supervision and Administration Regulation.
China’s National Medical Products Administration published the long-awaited final CSAR at the end of June. Industry stakeholders welcomed the framework regulation, generally seen as aligning China’s cosmetics oversight system more...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?